Scispot, a startup aiming to simplify the complex digital needs of the biotech sector, has closed an $8.0M Series A funding round led by Avenue Growth Partners. The investment will bolster the company's efforts to expand its unique, no-code tech stack, which it describes as the first-ever toolkit allowing biotech firms to tailor their digital infrastructure without requiring specialized coding skills.
The Scispot platform integrates alt-ELN, alt-LIMS, integrations, and analytics into a single, user-friendly system. It enables users to design data infrastructure, automate workflows, and prepare data for machine learning and artificial intelligence, offering pre-made blueprints for common experiments and data management.















